A Phase 1 TH-302 Mass Balance Trial
Clinical trial NCT02076230 · COMPLETED
Trial details
- NCT number
- NCT02076230
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-01
- Primary completion
- 2014-09-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.